Skip to main navigation Skip to search Skip to main content

Idarucizumab: a novel antidote for reversal of dabigatran.

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
JournalDepartment of Surgery
Publication statusPublished - 1 Mar 2016

Cite this